ONCR
Price:
$0.1205
Market Cap:
$0
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers. It is also developing ONCR-GBM, a preclinical stage oHSV program for treating brain cancer through intratumoral injection; and synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. The company has a clinical trial collaboration and supply agreement with MSD International GmbH to evaluate the safety and tolerability ...[Read more]
Industry
Biotechnology
IPO Date
2020-10-02
Stock Exchange
NASDAQ
Ticker
ONCR
According to Oncorus, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.74. This represents a change of -52.48% compared to the average of 3.65 of the last 4 quarters.
The mean historical Current Ratio of Oncorus, Inc. over the last ten years is 9.45. The current 1.74 Current Ratio has changed 1.74% with respect to the historical average. Over the past ten years (40 quarters), ONCR's Current Ratio was at its highest in in the March 2021 quarter at 25.93. The Current Ratio was at its lowest in in the September 2019 quarter at 0.
Average
9.45
Median
7.75
Minimum
1.74
Maximum
22.29
Discovering the peaks and valleys of Oncorus, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 139.81%
Maximum Annual Current Ratio = 22.29
Minimum Annual Increase = -72.39%
Minimum Annual Current Ratio = 1.74
Year | Current Ratio | Change |
---|---|---|
2022 | 1.74 | -71.79% |
2021 | 6.16 | -72.39% |
2020 | 22.29 | 139.81% |
2019 | 9.30 | 19.87% |
The current Current Ratio of Oncorus, Inc. (ONCR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
10.06
5-year avg
9.45
10-year avg
9.45
Oncorus, Inc.’s Current Ratio is less than eFFECTOR Therapeutics, Inc. (0), greater than Apollomics, Inc. (1.03), less than Angion Biomedica Corp. (2.25), greater than Sigilon Therapeutics, Inc. (1.74), less than Pyxis Oncology, Inc. (2.40), less than Zura Bio Limited (7.33), less than Altamira Therapeutics Ltd. (10.36), greater than Elevation Oncology, Inc. (1.38), less than Landos Biopharma, Inc. (17.77), less than Apexigen, Inc. (4.43), greater than Cardio Diagnostics Holdings, Inc. (1.29), less than null (8.51),
Company | Current Ratio | Market cap |
---|---|---|
0 | $941.00 | |
1.03 | $9.98M | |
2.25 | $30.11M | |
1.74 | $56.22M | |
2.40 | $112.90M | |
7.33 | $178.25M | |
10.36 | $1.60M | |
1.38 | $35.67M | |
17.77 | $71.68M | |
4.43 | $9.57M | |
1.29 | $10.73M | |
8.51 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncorus, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oncorus, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Oncorus, Inc.'s Current Ratio?
How is the Current Ratio calculated for Oncorus, Inc. (ONCR)?
What is the highest Current Ratio for Oncorus, Inc. (ONCR)?
What is the 3-year average Current Ratio for Oncorus, Inc. (ONCR)?
What is the 5-year average Current Ratio for Oncorus, Inc. (ONCR)?
How does the current Current Ratio for Oncorus, Inc. (ONCR) compare to its historical average?